The Manikin Study of Chest Compression With One Accelerometer Feedback Device

March 20, 2014 updated by: Lee Sang Hyun, Hanyang University Seoul Hospital

The Method of Proper Chest Compression Depth With Conventional and One Accelerometer Feedback Device During CPR in Hospital

Chest compression (CC) feedback devices are used to perform CC measurements effectively and accurately on patients in hospital beds. However, these devices do not take account of the compression of the mattress, which results in overestimation of CC depth. This study is the validation study to demonstrate that a new method using one accelerometer(U-cpr) is useful to overcome this limitation and thus measure compression depth more accurately when performing cardiopulmonary resuscitation (CPR) on patients.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Data collection The participants will be divided into three groups by random drawings. Each performer in the three-groups will compress the chest of the manikin on the bed with real-time 5cm,6cm and 7cm feed-back by one accelerometer (U-cpr).We will use two beds [Stryker ST104-747(Transport stretcher®, 760 x 2110 mm, 228 kg, Stryker Co., Kalamazoo, Michigan, US) ,Shinchang SB-34p (Transport stretcher® , 850 x 2080 mm,Shinchang Co.,Busan,ROK)]. Each participants will do 6 cycles of chest compression and 1cyle will be 2minutes. Between each cycles, participants will take a rest 5minutes.

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Postgraduates year 1,2,3,4 and Emergency physicians in emergency department

Exclusion Criteria:

  • Wrist or Low back disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: chest compression with 5cm feedback
We will feedback by one accelerometer (U-cpr). U-cpr is android based smartphone application.
Device: Stryker ST104-747
760 x 2110 mm, 228 kg, Stryker Co., Kalamazoo, Michigan, US
Other Names:
  • Transport stretcher®
Device: Shinchang SB-34p
, 850 x 2080 mm,Shinchang Co.,Busan,ROK
Other Names:
  • Transport stretcher®
Experimental: chest compression with 6cm feedback
We will feedback by one accelerometer(U-cpr). U-cpr is android based smartphone application.
Device: Stryker ST104-747
760 x 2110 mm, 228 kg, Stryker Co., Kalamazoo, Michigan, US
Other Names:
  • Transport stretcher®
Device: Shinchang SB-34p
, 850 x 2080 mm,Shinchang Co.,Busan,ROK
Other Names:
  • Transport stretcher®
Experimental: chest compression with 7cm feedback
We will feedback by one accelerometer(U-cpr). U-cpr is android based smartphone application.
Device: Stryker ST104-747
760 x 2110 mm, 228 kg, Stryker Co., Kalamazoo, Michigan, US
Other Names:
  • Transport stretcher®
Device: Shinchang SB-34p
, 850 x 2080 mm,Shinchang Co.,Busan,ROK
Other Names:
  • Transport stretcher®

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest compression depth
Time Frame: Within 1day
Primary out come is measured by Resusci Anne Modular System Skill Reporter manikin (9.89 kg, Laerdal Medical, Orpington, UK)
Within 1day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Chest compression rate
Time Frame: Within 1day
Secondary out is measured by Resusci Anne Modular System Skill Reporter manikin (9.89 kg, Laerdal Medical, Orpington, UK).
Within 1day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hanyang University Seoul Hospital

Investigators

  • Principal Investigator: Sang hyun Lee, M.D, Hanyang University Seoul Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

March 1, 2014

Study Completion (Actual)

March 1, 2014

Study Registration Dates

First Submitted

February 24, 2014

First Submitted That Met QC Criteria

February 25, 2014

First Posted (Estimate)

February 27, 2014

Study Record Updates

Last Update Posted (Estimate)

March 21, 2014

Last Update Submitted That Met QC Criteria

March 20, 2014

Last Verified

March 1, 2014

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2013-12-010-001

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiac Arrest

Clinical Trials on Stryker ST104-747

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe